ResearcherJohns Hopkins UniversityActive in the last 2 years
Asma Begum
Matched on ORCID iD 0009-0006-0405-2256; OpenAlex author ID A5054487398. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2017: 1 paper · 2018: none · 2019: 3 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- Reversible chemoresistance of pancreatic cancer grown as spheroids. Co-author DOI 10.1080/1120009x.2024.2402177↗
- Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma. Co-author DOI 10.1038/s41416-019-0683-3↗
- IQGAP1 Maintains Pancreatic Ductal Adenocarcinoma Clonogenic Growth and Metastasis. Co-author DOI 10.1097/mpa.0000000000001198↗
- Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function. Co-author DOI 10.1097/mpa.0000000000001249↗
- Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1541-7786.mcr-18-0367↗
- The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0180181↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zeshaan A. Rasheed · 5 shared papers, 2017–2025 · strength 0.52
- Paper Reversible chemoresistance of pancreatic cancer grown as spheroids. DOI 10.1080/1120009x.2024.2402177↗
- Paper Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untrea… DOI 10.1038/s41416-019-0683-3↗
- Paper Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function. DOI 10.1097/mpa.0000000000001249↗
- Christopher Lee Wolfgang · 3 shared papers, 2017–2025 · strength 0.35
- Paper Reversible chemoresistance of pancreatic cancer grown as spheroids. DOI 10.1080/1120009x.2024.2402177↗
- Paper Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function. DOI 10.1097/mpa.0000000000001249↗
- Paper The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal ad… DOI 10.1371/journal.pone.0180181↗
- William H. Matsui · 4 shared papers, 2017–2019 · strength 0.35
- Paper IQGAP1 Maintains Pancreatic Ductal Adenocarcinoma Clonogenic Growth and Metastasis. DOI 10.1097/mpa.0000000000001198↗
- Paper Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function. DOI 10.1097/mpa.0000000000001249↗
- Paper Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1541-7786.mcr-18-0367↗
- Anirban Maitra · 4 shared papers, 2017–2020 · strength 0.31
- Paper Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untrea… DOI 10.1038/s41416-019-0683-3↗
- Paper Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function. DOI 10.1097/mpa.0000000000001249↗
- Paper Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1541-7786.mcr-18-0367↗
- Michael Goggins · 2 shared papers, 2019–2025 · strength 0.30
- N.V. Rajeshkumar · 3 shared papers, 2017–2020 · strength 0.23
- Paper Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untrea… DOI 10.1038/s41416-019-0683-3↗
- Paper Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function. DOI 10.1097/mpa.0000000000001249↗
- Paper The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal ad… DOI 10.1371/journal.pone.0180181↗
- Vesselin R. Penchev · 3 shared papers, 2017–2019 · strength 0.22
- Paper Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function. DOI 10.1097/mpa.0000000000001249↗
- Paper Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/1541-7786.mcr-18-0367↗
- Paper The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal ad… DOI 10.1371/journal.pone.0180181↗
- Yoshihisa Matsushita · 1 shared paper, 2025 · strength 0.21
- Alexis L. Norris · 1 shared paper, 2025 · strength 0.21
- Yi Zhong · 1 shared paper, 2025 · strength 0.21
- James R. Eshleman · 1 shared paper, 2025 · strength 0.21
- Ralph H. Hruban MD · 1 shared paper, 2025 · strength 0.21
- Joey H. Li · 2 shared papers, 2019 · strength 0.21
- Robert A. Anders · 2 shared papers, 2019–2020 · strength 0.17
- Ana De Jesus‐Acosta · 2 shared papers, 2017–2020 · strength 0.14
- Paper Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untrea… DOI 10.1038/s41416-019-0683-3↗
- Paper The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal ad… DOI 10.1371/journal.pone.0180181↗
- Daniel A. Laheru · 2 shared papers, 2017–2020 · strength 0.14
- Paper Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untrea… DOI 10.1038/s41416-019-0683-3↗
- Paper The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal ad… DOI 10.1371/journal.pone.0180181↗
- Peter James O'Dwyer · 1 shared paper, 2020 · strength 0.09
- Shinichi Yabuuchi · 1 shared paper, 2020 · strength 0.09
- Bhavina D O Batukbhai · 1 shared paper, 2020 · strength 0.09
- Roeland F. de Wilde · 1 shared paper, 2020 · strength 0.09
- Ramesh K. Ramanathan · 1 shared paper, 2020 · strength 0.09
- Lei Zheng · 1 shared paper, 2020 · strength 0.09
- Florencia M. McAllister · 1 shared paper, 2020 · strength 0.09
- Daniel D. Von Hoff · 1 shared paper, 2020 · strength 0.09
- Laura DeLong Wood · 1 shared paper, 2017 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.